MedPath

TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz

Phase 2
Completed
Conditions
HIV Infections
Tuberculosis
Registration Number
NCT00023413
Lead Sponsor
Centers for Disease Control and Prevention
Brief Summary

The aim of this trial is to study the efavirenz-rifabutin interaction. Thus, this trial will enroll patients with HIV and tuberculosis co-infections who are receiving a rifabutin-based regimen and who plan to begin an antiretroviral regimen containing efavirenz dosed at 600 mg daily. Enrollment in TB Trials Consortium Study 23 is not a requirement for participation in this study.

Primary Objective:

To compare the pharmacokinetics of rifabutin at 600 mg twice a week in combination with efavirenz 600 mg daily to the pharmacokinetics of rifabutin 300 mg twice a week without efavirenz.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Compare PK of rifabutin 600mg twice weekly with efavirenz 600mg daily to PK of rifabutin 300mg twice weekly without efavirenz
Secondary Outcome Measures
NameTimeMethod
*Describe PK of rifabutin 600mg twice weekly in combination with efavirenz 600mg daily with 2 NRTI's
*Describe PK of efavirenz in this regimen
*Assess safety of concomitant rifabutin and efavirenz in HIV-TB

Trial Locations

Locations (23)

Central Arkansas Veterans Health System

🇺🇸

Little Rock, Arkansas, United States

LA County/USC Medical Center

🇺🇸

Los Angeles, California, United States

University of California, San Francisco

🇺🇸

San Francisco, California, United States

Denver Department of Public Health and Hospitals

🇺🇸

Denver, Colorado, United States

Washington, D.C. VAMC

🇺🇸

Washington, District of Columbia, United States

Chicago VA Medical Center (Lakeside)

🇺🇸

Chicago, Illinois, United States

Hines VA Medical Center

🇺🇸

Hines, Illinois, United States

Johns Hopkins University School of Medicine

🇺🇸

Baltimore, Maryland, United States

Boston Medical Center

🇺🇸

Boston, Massachusetts, United States

New Jersey Medical School

🇺🇸

Newark, New Jersey, United States

Scroll for more (13 remaining)
Central Arkansas Veterans Health System
🇺🇸Little Rock, Arkansas, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.